MedTrace Logo

Predictive Genetic Risk Assessment Trial

NCT00782366 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2011-04-27

No results posted yet for this study

Summary

This proof-of-principle clinical trial at Mayo Clinic studies how patients and their physicians understand and utilize predictive genetic risk assessment. A critical goal of this clinical trial is to understand how individual patients and their doctors perceive and respond to genetic risk information that is largely uncertain.

Conditions

Interventions

GENETIC

SNP analysis

The patients in the intervention group will obtain genetic risk assessments based on genome-wide association studies.

Sponsors & Collaborators

Principal Investigators

  • Kristina Tiedje, Ph.D. · Mayo Clinic

  • Clayton T. Cowl, M.D. · Mayo Clinic

  • Barbara A. Koenig, Ph.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00782366 on ClinicalTrials.gov